Japanese tree frog bacteria, Ewingella americana, intravenously eliminates colon tumors in mice by directly attacking cancer cells and activating the immune system, showing 100% complete response. This novel approach holds promise for solid tumor treatment.
Researchers identified ANKIB1 and K11-ubiquitin as crucial regulators of innate immune signaling and interferon production. This discovery offers therapeutic potential for diverse diseases, including cancer, neurodegenerative conditions, and inflammatory disorders.
Scientists are using infrared tags to track doxorubicin (DOX-IR) inside cancer cells, improving drug delivery and treatment effectiveness. This allows measuring drug concentration, opening doors for personalized cancer therapies.
